Adial pharmaceuticals reports first quarter 2024 financial results and provides business update

Glen allen, va., may 15, 2024 (globe newswire) -- adial pharmaceuticals, inc. (nasdaq: adil) (“adial” or the “company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today provided a business update and reported its financial results for the first quarter of 2024.
ADIL Ratings Summary
ADIL Quant Ranking